Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	0.91	-0.94	-9.02	-1.96	-27.97	-18.32
Depreciation & Amortization	0.94	0.9	1.77	0.46	0.65	0.45
Share-Based Compensation	3.09	3.14	4.22	3.38	2.58	1.89
Other Operating Activities	0.95	3.71	7.85	-6.61	2.4	-2.04
Operating Cash Flow	5.89	6.82	4.82	-4.72	-22.35	-18.03
Operating Cash Flow Growth	187.32%	41.36%	-	-	-	-
Capital Expenditures	-0.01	0	-0.04	0.69	-0.05	-1.1
Acquisitions	-1.87	0	0	0	0	0
Other Investing Activities	-0.78	-0.78	-2.75	-3.25	-	-0.75
Investing Cash Flow	-2.66	-0.78	-2.79	-2.56	-0.05	-1.85
Share Issuance / Repurchase	0.07	0.2	0.25	0.54	29.15	0.45
Debt Issued / Paid	-1.54	-1.16	-0.39	-0.15	2.48	4.75
Other Financing Activities	0.18	-	-	-	-	-
Financing Cash Flow	-1.29	-0.96	-0.13	0.39	31.63	5.2
Net Cash Flow	1.95	5.08	1.9	-6.89	9.23	-14.67
Free Cash Flow	5.88	6.82	4.78	-4.03	-22.4	-19.12
Free Cash Flow Growth	189.89%	42.48%	-	-	-	-
Free Cash Flow Margin	16.64%	20.88%	20.89%	-17.27%	-57425.64%	-1993.95%
Free Cash Flow Per Share	0.23	0.27	0.19	-0.16	-1.07	-1.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).